Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction

Akira Miyajima, Tomohiko Asano, Takako Asano, Ichiro Yoshimura, Kaori Seta, Masamichi Hayakawa

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Purpose: We determined whether tranilast, the anti-allergic agent N-(3, 4-dimethoxyciannamoyl)-anthranilic acid, would diminish renal transforming growth factor-β (TGF-β) levels in unilateral ureteral obstruction and concomitantly affect renal tubular apoptosis and proliferation in that condition. Materials and Methods: Tranilast (150 mg./kg.) was administered to rats 1 day before unilateral ureteral obstruction and each day thereafter. Kidneys were harvested day 14 after unilateral ureteral obstruction. Tissue TGF-β was measured by bioassay using mink lung epithelial cells. Renal tubular proliferation and apoptosis were detected by immunostaining proliferating cell nuclear antigen and the terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick end labeling assay, respectively. Fibrosis was assessed by measuring collagen deposition with trichrome stained slides. Results: TGF-β bioassay showed that obstructed kidneys in controls contained significantly higher mean TGF-β plus or minus standard deviation than unobstructed kidneys in controls (73.7 ± 13.6 versus 14.1 ± 5.5 pg./mg. tissue) and tranilast significantly decreased tissue TGF-β in obstructed kidneys (15.9 ± 4.8 pg./mg. tissue). The terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick end labeling assay demonstrated that obstructed kidneys in controls had significantly more mean tubular apoptosis than the unobstructed counterparts (36.6 ± 6.7 versus 5.8 ± 5.5 nuclei per high power field) and tranilast significantly decreased mean renal tubular apoptosis in obstructed kidneys (16.2 ± 1.7 nuclei per high power field). In addition, immunostaining proliferating cell nuclear antigen showed that obstructed kidneys in controls had significantly more mean renal tubular proliferation than unobstructed kidneys (20.7 ± 3.4 versus 6.2 ± 2.1 per high power field) and tranilast significantly increased proliferating renal tubules in obstructed and unobstructed kidneys (26.5 ± 8.3 and 14.5 ± 3.4 per high power field, respectively). Control obstructed kidneys exhibited significantly more fibrosis, which was also blunted by tranilast. Conclusions: Tranilast significantly decreases tissue TGF-β, resulting in a reduction in tubular apoptosis and an increase in tubular proliferation. This finding suggests that tranilast is a promising agent for preventing renal tubular damage in unilateral ureteral obstruction.

Original languageEnglish
Pages (from-to)1714-1718
Number of pages5
JournalJournal of Urology
Volume165
Issue number5 I
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Ureteral Obstruction
Kidney
Transforming Growth Factors
Apoptosis
DNA Nucleotidylexotransferase
tranilast
Proliferating Cell Nuclear Antigen
Biological Assay
Fibrosis
Renal Agents
Mink
Anti-Allergic Agents

Keywords

  • Anti-allergic agents
  • Apoptosis
  • Kidney
  • Transforming growth factor beta
  • Ureteral Obstruction

ASJC Scopus subject areas

  • Urology

Cite this

Miyajima, A., Asano, T., Asano, T., Yoshimura, I., Seta, K., & Hayakawa, M. (2001). Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. Journal of Urology, 165(5 I), 1714-1718.

Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. / Miyajima, Akira; Asano, Tomohiko; Asano, Takako; Yoshimura, Ichiro; Seta, Kaori; Hayakawa, Masamichi.

In: Journal of Urology, Vol. 165, No. 5 I, 2001, p. 1714-1718.

Research output: Contribution to journalArticle

Miyajima, A, Asano, T, Asano, T, Yoshimura, I, Seta, K & Hayakawa, M 2001, 'Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction', Journal of Urology, vol. 165, no. 5 I, pp. 1714-1718.
Miyajima A, Asano T, Asano T, Yoshimura I, Seta K, Hayakawa M. Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. Journal of Urology. 2001;165(5 I):1714-1718.
Miyajima, Akira ; Asano, Tomohiko ; Asano, Takako ; Yoshimura, Ichiro ; Seta, Kaori ; Hayakawa, Masamichi. / Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. In: Journal of Urology. 2001 ; Vol. 165, No. 5 I. pp. 1714-1718.
@article{5a1c4dfd3628465d9177d7675fafb1ce,
title = "Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction",
abstract = "Purpose: We determined whether tranilast, the anti-allergic agent N-(3, 4-dimethoxyciannamoyl)-anthranilic acid, would diminish renal transforming growth factor-β (TGF-β) levels in unilateral ureteral obstruction and concomitantly affect renal tubular apoptosis and proliferation in that condition. Materials and Methods: Tranilast (150 mg./kg.) was administered to rats 1 day before unilateral ureteral obstruction and each day thereafter. Kidneys were harvested day 14 after unilateral ureteral obstruction. Tissue TGF-β was measured by bioassay using mink lung epithelial cells. Renal tubular proliferation and apoptosis were detected by immunostaining proliferating cell nuclear antigen and the terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick end labeling assay, respectively. Fibrosis was assessed by measuring collagen deposition with trichrome stained slides. Results: TGF-β bioassay showed that obstructed kidneys in controls contained significantly higher mean TGF-β plus or minus standard deviation than unobstructed kidneys in controls (73.7 ± 13.6 versus 14.1 ± 5.5 pg./mg. tissue) and tranilast significantly decreased tissue TGF-β in obstructed kidneys (15.9 ± 4.8 pg./mg. tissue). The terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick end labeling assay demonstrated that obstructed kidneys in controls had significantly more mean tubular apoptosis than the unobstructed counterparts (36.6 ± 6.7 versus 5.8 ± 5.5 nuclei per high power field) and tranilast significantly decreased mean renal tubular apoptosis in obstructed kidneys (16.2 ± 1.7 nuclei per high power field). In addition, immunostaining proliferating cell nuclear antigen showed that obstructed kidneys in controls had significantly more mean renal tubular proliferation than unobstructed kidneys (20.7 ± 3.4 versus 6.2 ± 2.1 per high power field) and tranilast significantly increased proliferating renal tubules in obstructed and unobstructed kidneys (26.5 ± 8.3 and 14.5 ± 3.4 per high power field, respectively). Control obstructed kidneys exhibited significantly more fibrosis, which was also blunted by tranilast. Conclusions: Tranilast significantly decreases tissue TGF-β, resulting in a reduction in tubular apoptosis and an increase in tubular proliferation. This finding suggests that tranilast is a promising agent for preventing renal tubular damage in unilateral ureteral obstruction.",
keywords = "Anti-allergic agents, Apoptosis, Kidney, Transforming growth factor beta, Ureteral Obstruction",
author = "Akira Miyajima and Tomohiko Asano and Takako Asano and Ichiro Yoshimura and Kaori Seta and Masamichi Hayakawa",
year = "2001",
language = "English",
volume = "165",
pages = "1714--1718",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "5 I",

}

TY - JOUR

T1 - Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction

AU - Miyajima, Akira

AU - Asano, Tomohiko

AU - Asano, Takako

AU - Yoshimura, Ichiro

AU - Seta, Kaori

AU - Hayakawa, Masamichi

PY - 2001

Y1 - 2001

N2 - Purpose: We determined whether tranilast, the anti-allergic agent N-(3, 4-dimethoxyciannamoyl)-anthranilic acid, would diminish renal transforming growth factor-β (TGF-β) levels in unilateral ureteral obstruction and concomitantly affect renal tubular apoptosis and proliferation in that condition. Materials and Methods: Tranilast (150 mg./kg.) was administered to rats 1 day before unilateral ureteral obstruction and each day thereafter. Kidneys were harvested day 14 after unilateral ureteral obstruction. Tissue TGF-β was measured by bioassay using mink lung epithelial cells. Renal tubular proliferation and apoptosis were detected by immunostaining proliferating cell nuclear antigen and the terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick end labeling assay, respectively. Fibrosis was assessed by measuring collagen deposition with trichrome stained slides. Results: TGF-β bioassay showed that obstructed kidneys in controls contained significantly higher mean TGF-β plus or minus standard deviation than unobstructed kidneys in controls (73.7 ± 13.6 versus 14.1 ± 5.5 pg./mg. tissue) and tranilast significantly decreased tissue TGF-β in obstructed kidneys (15.9 ± 4.8 pg./mg. tissue). The terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick end labeling assay demonstrated that obstructed kidneys in controls had significantly more mean tubular apoptosis than the unobstructed counterparts (36.6 ± 6.7 versus 5.8 ± 5.5 nuclei per high power field) and tranilast significantly decreased mean renal tubular apoptosis in obstructed kidneys (16.2 ± 1.7 nuclei per high power field). In addition, immunostaining proliferating cell nuclear antigen showed that obstructed kidneys in controls had significantly more mean renal tubular proliferation than unobstructed kidneys (20.7 ± 3.4 versus 6.2 ± 2.1 per high power field) and tranilast significantly increased proliferating renal tubules in obstructed and unobstructed kidneys (26.5 ± 8.3 and 14.5 ± 3.4 per high power field, respectively). Control obstructed kidneys exhibited significantly more fibrosis, which was also blunted by tranilast. Conclusions: Tranilast significantly decreases tissue TGF-β, resulting in a reduction in tubular apoptosis and an increase in tubular proliferation. This finding suggests that tranilast is a promising agent for preventing renal tubular damage in unilateral ureteral obstruction.

AB - Purpose: We determined whether tranilast, the anti-allergic agent N-(3, 4-dimethoxyciannamoyl)-anthranilic acid, would diminish renal transforming growth factor-β (TGF-β) levels in unilateral ureteral obstruction and concomitantly affect renal tubular apoptosis and proliferation in that condition. Materials and Methods: Tranilast (150 mg./kg.) was administered to rats 1 day before unilateral ureteral obstruction and each day thereafter. Kidneys were harvested day 14 after unilateral ureteral obstruction. Tissue TGF-β was measured by bioassay using mink lung epithelial cells. Renal tubular proliferation and apoptosis were detected by immunostaining proliferating cell nuclear antigen and the terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick end labeling assay, respectively. Fibrosis was assessed by measuring collagen deposition with trichrome stained slides. Results: TGF-β bioassay showed that obstructed kidneys in controls contained significantly higher mean TGF-β plus or minus standard deviation than unobstructed kidneys in controls (73.7 ± 13.6 versus 14.1 ± 5.5 pg./mg. tissue) and tranilast significantly decreased tissue TGF-β in obstructed kidneys (15.9 ± 4.8 pg./mg. tissue). The terminal deoxynucleotidyl transferase mediated deoxyuridine triphosphate nick end labeling assay demonstrated that obstructed kidneys in controls had significantly more mean tubular apoptosis than the unobstructed counterparts (36.6 ± 6.7 versus 5.8 ± 5.5 nuclei per high power field) and tranilast significantly decreased mean renal tubular apoptosis in obstructed kidneys (16.2 ± 1.7 nuclei per high power field). In addition, immunostaining proliferating cell nuclear antigen showed that obstructed kidneys in controls had significantly more mean renal tubular proliferation than unobstructed kidneys (20.7 ± 3.4 versus 6.2 ± 2.1 per high power field) and tranilast significantly increased proliferating renal tubules in obstructed and unobstructed kidneys (26.5 ± 8.3 and 14.5 ± 3.4 per high power field, respectively). Control obstructed kidneys exhibited significantly more fibrosis, which was also blunted by tranilast. Conclusions: Tranilast significantly decreases tissue TGF-β, resulting in a reduction in tubular apoptosis and an increase in tubular proliferation. This finding suggests that tranilast is a promising agent for preventing renal tubular damage in unilateral ureteral obstruction.

KW - Anti-allergic agents

KW - Apoptosis

KW - Kidney

KW - Transforming growth factor beta

KW - Ureteral Obstruction

UR - http://www.scopus.com/inward/record.url?scp=0035043459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035043459&partnerID=8YFLogxK

M3 - Article

C2 - 11342962

AN - SCOPUS:0035043459

VL - 165

SP - 1714

EP - 1718

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 5 I

ER -